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WtBKER, Institut fur Strahlenbiologie, Uni-
versitat Munster.
The production of single strand breaks
(SSBs) and double strand breaks (DSBs) in
T2 DNA (16 ,ug/ml) by bleomycin (Bi)
(40 ,g/ml) was investigated quantitatively.
At 5°C 0.11 SSB/min per T2 genom were
found. The addition of 1 mmol cysteamine
(SH) enhances the single strand breakage rate
by a factor of25. DSBs were found at a rate
of 0-5/min only in the presence of SH and Bi.
Since the accidental DSB rate due to SSBs in
opposite DNA strands is less than 10-3/min
per T2 genom DSBs must be produced
directly by the action of Bi. The obtained
DNA profiles did not follow a random
distribution; thus bleomycin apparently acts
at specific sites along the T2 genom. X-
irradiation followed by BI-SH treatment
resulted in an increased DNA degradation.
The number of SSBs is at least 3 times larger
than expected ifthe effect ofboth treatments
is just additive.
MODIFICATION OF THE RESPONSE
OF MOUSE SKIN TO X-IRRADIA-
TION BY BLEOMYCIN TREATMENT.
J. T. LEITH and B. S. LEWINSKY, Lawrence
Berkeley Laboratory, UniversityofCalifornia.
Skin reactions occurring on the legs of
mice after 230 kV x-irradiation were used to
investigate the combined effects of x-irradia-
tion and bleomycin. Bleomycin was given
daily for 5 days (5 mg/kg/day), either pre-
ceding or following graded single doses of
x-rays. Skin reactions occurring after com-
bined treatment were compared with skin
reactions produced by x-irradiation alone.
Both bleomycin schemes yielded average
1-30 day post-irradiation skin reactions
greater than skin reactions seen after x-
irradiation alone. Dose-response curves for
the combined treatments were parallel to the
x-irradiation alone treatment, but were dis-
placed upwards. The responses obtained in
the 2 bleomycin schemes were not signifi-
cantly different. The dose modifying effect
of the bleomycin treatments ranged from
1-5 at low levels of effect to 1 2 at higher
levels of effect. It is concluded that the
combined effects of bleomycin and x-irradia-
tion in this design were additive. In a second
series ofexperiments, the ability ofbleomycin
to affect the ability of mouse skin to recovery
from radiation injury in a fractionated
experiment (3F/4D) was studied. Bleomycin
was found to apparently decrease, by about
30%0, the repair of sublethal radiation
damage when given simultaneously with the
radiation exposure (5 mg/kg).
RADIATION AND ANTI-TUMOUR
DRUGS. M. BARKER-GRIMSHAW, K. HELL-
MANN and G. E. MURKIN, Chemotherapy
Department, Imperial Cancer Research Fund,
London.
Growth inhibitory effects of the anti-
tumour drugs 5-flourouracil, adriamycin,
hydroxyurea, bleomycin, cyclophosphamide,
methotrexate, ICRF 159 and 593A and the
radiosensitizer Ro-07-0582 combined with a
standard dose of radiation was tested on the
radiosensitive sarcoma 180. The most effec-
tive potentiators were 593A and ICRF 159.
They were then examined against the
relatively radioresistant Lewis lungcarcinoma
and melanoma B16 using either single doses
of drug and radiotherapy or the same total
dose given in fractions over 5 days. 593A
was equally potent whether given as a single
maximum tolerated dose or in divided doses;
ICRF 159 was ineffective when given as a
single low dose (though it was effective given
in a single high dose), but highly effective in
divided low doses. Clinical trials with
ICRF 159 in combination with radiotherapy
are in progress.
EFFECT OF LUCANTHONE ON THE
RADIOSENSITIVITY OF A MOUSE
TUMOUR. K. R. RAO and H. FRITZ-
NIGGLI, Radiobiology Institute of Zurich
University.
Lucanthone is reported to be carcinostatic
(Hirschberg et al., J. natn. Cancer Inst., 1959,
22, 567) and a radiosensitizer (Bases, Cancer
Res., 1970, 30, 2007). But in our study
lucanthone alone (70 mg/kg body weight) had
no lasting effect on the Ehrlich carcinoma in
mice. Based on mitotic studies, 4-day old
ascites tumour was not sensitized to x-rays
when pretreated with lucanthone. Tumour
growth, evaluated as the average weight of
solid tumours or the number of tumour cells
in ascites bearing mice, was not significantly
different between the group treated with
x-rays only and the one treated with lucan-
thone plus x-rays. Thus, lucanthone seems to
enhance the radiosensitivity of normal cell